Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study

BACKGROUND: Prospectively and systematically collected real-world data on vedolizumab are scarce. We aimed to assess the long-term clinical effectiveness of vedolizumab in inflammatory bowel disease (IBD). METHODS: This study was a prospective, observational, multicentre study. Overall, 286 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksson, Carl, Rundquist, Sara, Lykiardopoulos, Vyron, Udumyan, Ruzan, Karlén, Per, Grip, Olof, Söderman, Charlotte, Almer, Sven, Hertervig, Erik, Marsal, Jan, Gunnarsson, Jenny, Malmgren, Carolina, Delin, Jenny, Strid, Hans, Sjöberg, Mats, Öberg, David, Bergemalm, Daniel, Hjortswang, Henrik, Halfvarson, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255566/
https://www.ncbi.nlm.nih.gov/pubmed/34276808
http://dx.doi.org/10.1177/17562848211023386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255566/
https://www.ncbi.nlm.nih.gov/pubmed/34276808
http://dx.doi.org/10.1177/17562848211023386

Ejemplares similares